Future Growth Prospects of the Stem Cell Manufacturing Market 2035
The cell therapy landscape is witnessing a major strategic shift from autologous treatments—which use a patient's own cells—toward allogeneic therapies derived from healthy universal donors. While autologous approaches require custom, small-scale manufacturing for individual patients, allogeneic models enable "off-the-shelf" production batches capable of treating thousands of...
0 Comments 0 Shares 7 Views 0 Reviews